Epirubicin
Anthracyclines and Related Substances
- Drug class
- Anthracyclines and Related Substances
- Availability
- See label
- Routes
- Intravenous
- Markets covered
- 2
- Products on record
- 14
Overview
Epirubicin is an active pharmaceutical ingredient in the Anthracyclines and Related Substances group (L01DB). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 10 | May 22, 2026 |
| CA Canada | Health Canada | 4 | May 22, 2026 |
GBUnited Kingdom· MHRA
10 products
Uses
Epirubicin is used in the treatment of a range of neoplastic conditions including: - Breast carcinoma - Gastric carcinoma When administered intravesically, epirubicin has been shown to be beneficial in the treatment of: - Papillary transitional cell carcinoma of the bladder - Carcinoma in-situ - Intravesical prophylaxis of recurrence of superficial bladder carcinoma following transurethral resection.
Epirubicin hydrochloride 2 mg/ml can be used in polychemotherapy schedules.
How to take
CACanada· Health Canada
4 products
Uses
AND CLINICAL USE .......................................................................................... 4 CONTRAINDICATIONS ................................................................................................................
4 WARNINGS AND PRECAUTIONS .............................................................................................. 5 ADVERSE REACTIONS ..............................................................................................................
11 DRUG INTERACTIONS ............................................................................................................... 14 DOSAGE AND ADMINISTRATION...........................................................................................
15 OVERDOSAGE ............................................................................................................................. 18 ACTION AND CLINICAL PHARMACOLOGY .........................................................................
Drug interactions
Known interactions involving Epirubicin. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 438. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL002891162 · revised May 22, 2026
- [2]Health Canada (DPD) · 02413221 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.